The Company Not even own a 100% of Marigold lol Marigold Receives Five Conditional Cannabis Related Licenses TORONTO, March 22, 2018 (GLOBE NEWSWIRE) -- Scythian Biosciences Corp. (the "Company" or Scythian) (TSXV:SCYB) (Frankfurt:9SB) (OTC Pink:SCCYF) is pleased to announce that it has entered into a binding letter of intent dated March 21, 2018 (Letter of Intent) to acquire Marigold Acquisitions Inc. (the Acquisition). The Acquisition will result in Scythian becoming a major stakeholder of Marigold Projects Jamaica Ltd. (Marigold), a Jamaican company, which has received conditional licenses to cultivate, process, sell and provide therapeutic or spa services utilizing cannabis products. In consideration, Scythian will issue 1,500,000 common shares at the current price per share of $23.00 to the selling parties. Following completion of the Acquisition, the Marigold Receives Five Conditional Cannabis Related Licenses TORONTO, March 22, 2018 (GLOBE NEWSWIRE) -- Scythian Biosciences Corp. (the "Company" or Scythian) (TSXV:SCYB) (Frankfurt:9SB) (OTC Pink:SCCYF) is pleased to announce that it has entered into a binding letter of intent dated March 21, 2018 (Letter of Intent) to acquire Marigold Acquisitions Inc. (the Acquisition). The Acquisition will result in Scythian becoming a major stakeholder of Marigold Projects Jamaica Ltd. (Marigold), a Jamaican company, which has received conditional licenses to cultivate, process, sell and provide therapeutic or spa services utilizing cannabis products. In consideration, Scythian will issue 1,500,000 common shares at the current price per share of $23.00 to the selling parties. Following completion of the Acquisition, the Company will own a 49% interest in Marigold as well as a 95% royalty interest in the net revenues from products sold by Marigold as well as a 95% royalty interest in the net revenues from products sold by Marigold